Clinical Directors Network Inc is located in New York, NY. The organization was established in 1994. According to its NTEE Classification (H99) the organization is classified as: Medical Research N.E.C., under the broad grouping of Medical Research and related organizations. As of 12/2021, Clinical Directors Network Inc employed 20 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Clinical Directors Network Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Clinical Directors Network Inc generated $4.0m in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 4.4% each year. All expenses for the organization totaled $3.7m during the year ending 12/2021. While expenses have increased by 3.7% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
THE ORGANIZATION PROMOTES PROFESSIONAL EXCELLENCE AMONG ITS MEMBERSHIP, AND PROVIDES ACCREDITED CONTINUING MEDICAL (CME) DENTAL (CDE) NURSING (CNE), COMMUNITY HEALTH EDUCATION (CHES) AND SOCIAL WORK (CE-SW) EDUCATIONALACTIVITIES, BOTH IN PERSON AND ON-LINE, AS WELL AS CONDUCTING PRACTICE-BASED CLINICAL AND TRANSLATIONAL RESEARCH AND PUBLIC HEALTH PROGRAMS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
PREVENTING TIPPING POINTS IN HIGH COMORBIDITY PATIENTS: A LIFETIME FROM HEALTH COACHESPROTECTING THE MENTAL AND PHYSICAL WELL-BEING OF FRONTLINE HEALTHCARE WORKERS DURING COVID-19: THE COVER-HCW PROJECTCOLLABORATIONS FOR HEALTH AND EMPOWERED COMMUNITY-BASED SCIENTISTS (CHECS)PATIENT-CENTERED HCV CARE VIA TELEMEDICINE FOR INDIVIDUALS ON OPIATE SUBSTITUTION THERAPY: A STEPPED WEDGE CLUSTER RANDOMIZED CONTROLLED TRIAL
GUIDE TO IMPROVING PATIENT SAFETY IN PRIMARY CARE SETTINGS BY ENGAGING PATIENTS AND FAMILIESGET READY AND EMPOWERED ABOUT TREATMENT (GREAT2) IMPLEMENTATION RESEARCH: TRANSLATING THE ABCS INTO HIV CAREDYNAMICALLY TAILORING INTERVENTIONS FOR PROBLEM-SOLVING IN DIABETES SELF MANAGMENT USING SELF-MONITORING DATA (MODD2)BUILDING EXPERIENCE FOR TREATING TRAUMA AND ENHANCING RESILIENCE (BETTER) PROJECTBRIEF INTERVENTION TO EVALUATE ASTHMA THERAPY (BREATHE) STUDYACCREDITED CONTINUING MEDICAL, DENTAL, NURSING COMMUNITY, HEALTH EDUCATION AND SOCIAL WORK ACTIVITIES
SYNEOS - ER/LA - EXTENDED RELEASE/LONG ACTING OPIOID POST-MARKETING REQUIREMENT STUDIES TO PROVIDE QUATITATIVE ESTIMATES OF THE SERIOUS RISKS OF MISUSE, ABUSE, ADDICTION, OVERDOSE, AND DEATH ASSOCIATED WITH LONG-TERM USE OF OPIOID ANALGESICS FOR MANAGEMENT OFCHRONIC PAIN, AMONG PATIENTS PRESCRIBED ER/LA OPIOID PRODUCTS.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Jonathan N Tobin PHD President & CEO | Officer | 40 | $361,830 |
Andrea N Donaldson Director Of Clinical Affairs | 40 | $151,762 | |
Avi Silber MD Chairman | OfficerTrustee | 0.5 | $0 |
Sara Palomino Dnp RN Fnp Past Chairman | OfficerTrustee | 0.5 | $0 |
Nancy Piper Jenks Ms Cfnp Treasurer | OfficerTrustee | 0.5 | $0 |
Liliana Lombardi Secretary | OfficerTrustee | 0.5 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $1,205,341 |
All other contributions, gifts, grants, and similar amounts not included above | $2,635,212 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $3,840,553 |
Total Program Service Revenue | $143,355 |
Investment income | $5,994 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $3,992,902 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $513,592 |
Compensation of current officers, directors, key employees. | $137,129 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $793,681 |
Pension plan accruals and contributions | $108,070 |
Other employee benefits | $194,435 |
Payroll taxes | $90,983 |
Fees for services: Management | $0 |
Fees for services: Legal | $7,920 |
Fees for services: Accounting | $225,758 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $95,439 |
Advertising and promotion | $0 |
Office expenses | $76,683 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $140,701 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $1,442 |
Insurance | $13,728 |
All other expenses | $13,003 |
Total functional expenses | $3,690,516 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $481,490 |
Savings and temporary cash investments | $1,100,213 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $822,015 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $31,830 |
Net Land, buildings, and equipment | $2,165 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $35,625 |
Total assets | $2,473,338 |
Accounts payable and accrued expenses | $764,986 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $402,639 |
Total liabilities | $1,167,625 |
Net assets without donor restrictions | $1,305,713 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $2,473,338 |
Over the last fiscal year, we have identified 1 grants that Clinical Directors Network Inc has recieved totaling $283,059.
Awarding Organization | Amount |
---|---|
Columbia University In The City Of New York New York, NY PURPOSE: Research | $283,059 |
Organization Name | Assets | Revenue |
---|---|---|
Lankenau Institute For Medical Research Wynnewood, PA | $8,021,343 | $9,109,367 |
Tri-Institutional Therapeutics Discovery Institute Inc New York, NY | $5,819,394 | $16,905,997 |
Community Partners In Action Inc Hartford, CT | $16,042,672 | $16,238,720 |
Zachary And Elizabeth M Fisher Center For Alzheimers Research Fdn New York, NY | $40,802,431 | $10,021,313 |
Coalition Of Cancer Cooperative Groups Philadelphia, PA | $21,235,863 | $14,701,631 |
American Thrombosis And Hemostasisnetwork Inc Rochester, NY | $10,168,996 | $13,364,540 |
Football Research Inc New York, NY | $4,325,864 | $9,164,438 |
Institute For Protein Innovation Inc Boston, MA | $219,080,402 | $200,786,087 |
Center For Information And Study On Clinical Research Participation Boston, MA | $5,283,770 | $9,262,941 |
Vermont Oxford Network Inc Burlington, VT | $14,865,425 | $8,539,572 |
National Disease Research Interchange Philadelphia, PA | $6,059,781 | $7,072,153 |
Bronx Veterans Medical Research Foundation Inc Bronx, NY | $9,078,068 | $8,272,955 |